AstraZeneca sweeps away the MedImmune name as CEO Soriot restructures R&D

AstraZeneca sweeps away the MedImmune name as CEO Soriot restructures R&D

Source: 
Endpoints
snippet: 

MedImmune is history.

AstraZeneca execs acknowledged today that the company is sweeping the MedImmune brand name away as CEO Pascal Soriot streamlines the R&D organization, carving the group into 2 parts.